09/16/2020

Hospitals Urge HHS to Step in on 340B Fight with Drug Manufacturers

The American Hospital Association on Tuesday sent another letter to HHS about the 340B drug discount program, asking the department to stop drug manufacturers from limiting distribution of medicines covered by the program and asking for detailed information about distribution through hospital's contract pharmacy arrangements.  It follows a similar July letter protesting action from Eli Lilly and Merck. AHA said Sanofi, Novartis and AstraZeneca have followed suit with what the group calls "abusive tactics."  READ MORE